Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Rapidly eliminated in feces and urine

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential
Absorption rate - oral (%):
50
Absorption rate - dermal (%):
10
Absorption rate - inhalation (%):
100

Additional information

Using radiolabeled test material, the absorption, distribution and elimination of CPC after oral and intravenous administration was investigated in rats and Beagle dogs. The substance is primarily eliminated in the feces, up to 85% after oral administration and up to 37% after intravenous dosing. After oral dosing, the secondary route of elimination is the urine, approximately 5% after oral administration, and up to 32% route after intravenous dosing. No information is available concerning the metabolism of CPC (other than its conjugation with bile salts). A conservative value of 50% oral absorption may be applied, as per EFSA (2012). Considering the substance is a charged molecule, the dermal absorption is low, and a value of 10%, as per SCCS (2015), is applied.